Table 1.
1. Chance |
2. Placebo group patients improved “too much” |
3. The optimal patients and phenotypes were not studied |
4. Existing outcome measures have limited responsiveness to treatment effects |
5. Temporal changes in characteristics of patients enrolling in trials |
6. Temporal changes in types of clinical sites conducting trials |
7. Research subject misbehaviour |
8. Research site unintentional bias and misconduct |
9. Inadequate sample sizes |